Africa Holguin | Microbiology | Best Researcher Award

Dr. Africa Holguin | Microbiology | Best Researcher Award

Dr. Africa Holguin | Microbiology – Investigador at Instituto Ramón y Cajal de Investigación Sanitaria – IRYCIS, Spain

Dr. Africa Holguín is a globally respected virologist and the Head of the HIV-1 Molecular Epidemiology Laboratory at IRYCIS – Hospital Ramón y Cajal in Madrid, Spain. Her work has significantly advanced the global understanding of HIV genetic variability, antiretroviral resistance, and viral surveillance. She has been a leading figure in molecular virology research for over two decades and is especially recognized for her studies on non-B HIV-1 subtypes, viral quasispecies, and the epidemiological patterns of drug resistance mutations. With over 5,300 citations and more than 100 publications, Dr. Holguín is a key contributor to the global HIV research community and a scientific leader in infectious disease molecular diagnostics.

Academic Profile:

ORCID

Scopus

Google Scholar

Education:

Dr. Holguín completed her graduate studies in biological sciences with a specialization in virology and molecular biology. Her academic training emphasized molecular diagnostics and viral genomics, providing her with the tools to engage in complex viral surveillance projects. She later deepened her specialization in infectious diseases through advanced research training, equipping her to lead cross-disciplinary studies on the molecular epidemiology of HIV and other RNA viruses.

Experience:

With over 25 years of experience in clinical virology and molecular epidemiology, Dr. Holguín has led numerous high-impact national and international research projects. Her role as the head of a specialized research laboratory has allowed her to supervise a range of HIV-related studies, including drug resistance surveillance, viral genetic analysis, and epidemiological modeling. She collaborates with global health bodies and research consortia and has worked extensively on patient cohorts including immigrants, children, and treatment-naïve populations. She also provides expert input for public health decision-making and clinical guideline development.

Research Interests:

Dr. Holguín’s research focuses on the molecular evolution of HIV-1, especially non-B subtypes, and how natural genetic polymorphisms affect treatment outcomes. She investigates antiretroviral resistance, viral quasispecies, and genetic recombination events that impact diagnosis and therapy. Her interests extend to real-world applications, such as viral load testing accuracy and genotype interpretation systems. Recently, she has contributed to molecular surveillance of SARS-CoV-2, showcasing her adaptability and leadership in emerging infectious disease research.

Awards:

Dr. Holguín has received multiple accolades and recognitions for her contributions to virology and public health. Her work has influenced global HIV treatment strategies, and she has participated in advisory panels and policy-shaping discussions at the national and international level. She has also received institutional recognition for her mentorship and leadership in scientific research and has played a key role in developing Spain’s HIV molecular monitoring infrastructure.

Selected Publications 📚:

  1. 📘 “Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review” – The Lancet Infectious Diseases, 2019 – Cited by 457
  2. 📗 “Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype” – PLoS Medicine, 2005 – Cited by 393
  3. 📙 “Pol gene quasispecies of HIV: mutations associated with drug resistance in untreated patients” – Journal of Virology, 1995 – Cited by 274
  4. 🧬 “Evolution of SARS-CoV-2 structural proteins from the start of the pandemic to September 2020” – Viruses, 2021 – Cited by 113
  5. 📒 “High prevalence of HIV-1 subtype G and natural polymorphisms among immigrants in Madrid” – AIDS, 2002 – Cited by 98
  6. 📕 “Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis in immigrant sex workers in Spain” – Journal of Medical Virology, 2004 – Cited by 83
  7. 📓 “Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes” – AIDS Reviews, 2006 – Cited by 81

Conclusion:

Dr. Africa Holguín’s remarkable research record, impactful collaborations, and long-term leadership in the field of HIV molecular epidemiology make her a strong candidate for the Best Researcher Award. Her commitment to scientific excellence, especially in the areas of viral resistance and subtype diversity, has contributed to meaningful advancements in clinical care and global health policy. With a strong citation record, consistent publication output, and a multidisciplinary approach to emerging infectious diseases, Dr. Holguín exemplifies the qualities of an outstanding researcher whose work continues to shape the future of virology and public health.

 

 

Marcos Herkenhoff | Microbiology | Best Researcher Award

Dr. Marcos Herkenhoff | Microbiology | Best Researcher Award

Post doctoral | University of São Paulo | Brazil

Marcos Herkenhoff is a distinguished researcher and veterinarian specializing in molecular diagnostics, genetics, and multiomics. With advanced degrees in veterinary medicine and genetics, and extensive international experience, he has contributed significantly to various scientific fields, including animal health, brewing technology, and nutrigenomics. Herkenhoff has published numerous articles, funded multiple research projects, and is recognized for his innovative work on probiotic beers and genetic markers in animals.

Profile

SCOPUS

Education

Marcos Herkenhoff completed his Doctorate in Veterinary Medicine at Santa Catarina State University (UDESC) in 2010, followed by a Master’s degree in Animal Science (Animal Production) in 2013. He earned his Ph.D. in Biological Sciences (Genetics) from São Paulo State University “Júlio de Mesquita Filho” (UNESP-Botucatu) in 2017, with postdoctoral research at the University of São Paulo (USP) from 2019 to 2024.

Experience

Herkenhoff’s professional experience spans roles as a founding partner and responsible veterinarian at Equus Group, where he focused on equine genetics and athletic performance traits. He has also worked as a postdoctoral researcher in food technology, developing a non-alcoholic probiotic beer, and served as a research assistant and guest researcher at Technische Hochschule Wildau in Germany. His teaching roles included assistant professor positions in molecular genetics and animal improvement.

Research Interest

Herkenhoff’s research interests include human and animal molecular diagnostics, population genetics, immunogenetics, and multiomics. His work explores genetic potential optimization in livestock, enhances animal health, and improves industrial fermentation processes. Notable projects include the development of a probiotic beer and investigations into the genetic markers for athletic performance.

Awards

Herkenhoff has received multiple grants from FAPESP for his research projects. His innovative contributions to molecular diagnostics and multiomics applications in brewing technology and genetics have been recognized within the scientific community.

Publication

Herkenhoff, M. E.; Brödel, O.; Frohme, M. Aroma component analysis by HS-SPME/GC–MS to characterize Lager, Ale, and sour beer styles. Food Research International, in-press, 2024.

Herkenhoff, M. E.; Medeiros, I.U.D.; Garutti, L.H.G.; Salgaco, M.K.; Sivieri, K.; Saad, S.M.I. Prebiotic and probiotic potential of fermented milk with cashew (Anacardium occidentale) by-products evaluated in microbiome model. Food Bioscience, v. 61, p. 104669, 2024.

Herkenhoff, M. E. The Probiotic Paradox: Thriving in High-Hopped Sour Beer. Journal of the American Society of Brewing Chemists, v. 1, p. 1-9, 2024.

Herkenhoff, M.E.; De Medeiros, I.U.D.; Garutti, L.H.G.; Salgaco, M.K.; Sivieri, K.; Saad, S.M.I. Cashew By-Product as a Functional Substrate for the Development of Probiotic Fermented Milk. Foods, v. 12, p. 3383, 2023.

Herkenhoff, M. E.; Bajay, M.M.; Costamilan, C.A.V.L.R. Genetic Structure and Biodiversity in Wild Centropomus parallelus and in Wild and Recently Domesticated Centropomus undecimallis Populations. Life-Basel, v. 13, p. 1595, 2023.

Herkenhoff, M. E.; Battistini, C.; Praia, A. B.; Rossini, B. C.; dos Santos, L. D.; Brödel, O.; Frohme, M.; Saad, S. M. I. The combination of omics strategies to evaluate starter and probiotic strains in the Catharina sour Brazilian-style beer. FOOD RESEARCH INTERNATIONAL, v.167, p.112704, 2023.

Praia, A.B.; Herkenhoff, M.E.; Broedel, O.; Frohme, M.; Saad, S.M.I. Sour Beer with Lacticaseibacillus paracasei subsp. paracasei F19: Feasibility and Influence of Supplementation with Spondias mombin L. Juice and/or By-Product. FOODS, v. 11, p. 4068, 2022.

Herkenhoff, M. E.; Bovolenta, L. A.; Broedel, O.; dos Santos, L. D.; de Oliveira, A. C.; Chuffa, L. G.A.; Ribeiro, A. O.; Lupi, Luiz A.; Dias, M.A.D.; Hilsdorf, A.W.S.; Frohme, M.; Pinhal, D. Variant expression signatures of microRNAs and protein related to growth in a crossbreed between two strains of Nile tilapia (Oreochromis niloticus). GENOMICS, v. 113, p. 4303-4312, 2021.

Ribeiro, A.O.; Oliveira, A.C.; Costa, J.M.; Nachtigall, P.G.; Herkenhoff, M.E.; Campos, V.F.; Delella, F.K.; Pinhal, D. MicroRNA roles in regeneration: Multiple lessons from zebrafish. DEVELOPMENTAL DYNAMICS, v. 1, p.01 – 21, 2021.

Battistini, C.; Herkenhoff, M. E.; de Souza Leite, M.; Vieira, A. D. S.; Bedani, R.; Saad, S. M. I. Brewer’s Spent Grain Enhanced the Recovery of Potential Probiotic Strains in Fermented Milk After Exposure to In Vitro-Simulated Gastrointestinal Conditions. Probiotics and Antimicrobial Proteins, v. 1, p. 01, 2021.

Conclusion

Marcos Herkenhoff is a highly qualified candidate for the Best Researcher Award. His diverse expertise, international experience, and significant contributions to science make him a strong contender. To further strengthen his candidacy, focusing on specialized areas within his broad research interests and emphasizing the practical applications and societal impact of his work would be beneficial. Overall, his impressive achievements and active role in advancing scientific knowledge position him as a worthy candidate for this award.